Ligand validation:6AVI

GW9: 2-chloro-5-nitro-N-phenylbenzamide

GW9 is a Ligand Of Interest in 6AVI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AVI_GW9_B_501	41%	39%	0.181	0.897	1.26	1.13	2	1	1	0	100%	0.9474
6AVI_GW9_A_501	14%	47%	0.279	0.827	1.29	0.78	3	-	2	0	100%	0.9474
8FHE_GW9_B_501	82%	45%	0.096	0.95	1.36	0.8	3	-	1	0	100%	0.9474
3B0R_GW9_B_1	57%	55%	0.124	0.897	0.62	1.11	-	2	0	0	100%	0.9474
8ZFN_GW9_B_501	44%	27%	0.176	0.904	1.53	1.43	4	2	2	0	100%	0.9474
8ZFP_GW9_A_501	37%	53%	0.237	0.935	1.38	0.46	2	-	2	0	100%	0.9474
8ZFO_GW9_B_501	9%	5%	0.314	0.818	1.41	3.99	4	8	9	0	95%	0.9474
6KYP_GW9_A_501	44%	45%	0.214	0.944	1.42	0.71	4	-	2	0	100%	0.9474

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.